Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)
CUSIP: 45258J102
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 202,731,676
- Total 13F shares
- 94,088,777
- Share change
- +14,628,339
- Total reported value
- $1,608,317,726
- Put/Call ratio
- 97%
- Price per share
- $17.09
- Number of holders
- 191
- Value change
- +$221,642,111
- Number of buys
- 125
- Number of sells
- 71
Quarterly Holders Quick Answers
What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45258J102:
Top shareholders of IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6.5%
|
13,097,915
|
$324,435,352 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
6,679,414
|
$165,449,085 | — | 31 Dec 2024 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
5.6%
from 13D/G
|
6,000,000
|
$148,620,000 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
2.5%
|
5,143,071
|
$127,393,868 | — | 31 Dec 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.5%
|
5,117,234
|
$126,754,000 | — | 31 Dec 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.9%
|
3,870,586
|
$95,874,415 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
2,697,522
|
$66,817,620 | — | 31 Dec 2024 | |
| Alpine Global Management, LLC |
13F
|
Company |
1.1%
|
2,158,904
|
$53,476,052 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.1%
|
2,139,199
|
$52,987,959 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.84%
|
1,707,881
|
$42,304,212 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.75%
|
1,515,020
|
$37,536,428 | — | 31 Dec 2024 | |
| Two Seas Capital LP |
13F
|
Company |
0.75%
|
1,511,614
|
$37,442,679 | — | 31 Dec 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.69%
|
1,407,290
|
$34,858,573 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.58%
|
1,175,685
|
$29,121,717 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.57%
|
1,153,338
|
$28,568,183 | — | 31 Dec 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.57%
|
1,145,618
|
$28,376,958 | — | 31 Dec 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.55%
|
1,118,508
|
$27,705,443 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.5%
|
1,010,624
|
$25,033,156 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.49%
|
984,063
|
$24,375,241 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.45%
|
916,250
|
$22,696,000 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.45%
|
915,151
|
$22,668,290 | — | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.45%
|
909,103
|
$22,518,481 | — | 31 Dec 2024 | |
| Boxer Capital Management, LLC |
13F
|
Company |
0.41%
|
825,000
|
$20,435,250 | — | 31 Dec 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.39%
|
791,863
|
$19,614,143 | — | 31 Dec 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.39%
|
787,478
|
$19,505,830 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.33%
|
678,346
|
$16,802,631 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.32%
|
642,726
|
$15,920,323 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.31%
|
637,947
|
$15,801,947 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.29%
|
590,764
|
$14,633,226 | — | 31 Dec 2024 | |
| Julia G. Butchko |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
509,682
mixed-class rows
|
$14,251,795 | — | 21 Aug 2024 | |
| Redmile Group, LLC |
13F
|
Company |
0.28%
|
571,824
|
$14,164,080 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
564,442
|
$13,981,228 | — | 31 Dec 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.26%
|
532,110
|
$13,180,365 | — | 31 Dec 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.26%
|
530,614
|
$13,143,309 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
527,367
|
$13,062,881 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.25%
|
505,591
|
$12,523,489 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.25%
|
504,032
|
$12,484,873 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.22%
|
444,013
|
$10,998,202 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.2%
|
403,747
|
$9,999,569 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
341,535
|
$8,459,822 | — | 31 Dec 2024 | |
| Mark S. Levine |
3/4/5
|
Chief Legal Officer |
—
mixed-class rows
|
387,951
mixed-class rows
|
$8,124,353 | — | 20 Nov 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
310,330
|
$7,686,875 | — | 31 Dec 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.15%
|
305,523
|
$7,567,805 | — | 31 Dec 2024 | |
| William L. Macias |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
426,076
mixed-class rows
|
$7,454,384 | — | 19 Feb 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.15%
|
300,000
|
$7,431,000 | — | 31 Dec 2024 | |
| Logos Global Management LP |
13F
|
Company |
0.15%
|
300,000
|
$7,431,000 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.14%
|
279,252
|
$6,917,072 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.12%
|
245,650
|
$6,084,751 | — | 31 Dec 2024 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.12%
|
244,558
|
$6,057,702 | — | 31 Dec 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.12%
|
235,884
|
$5,842,847 | — | 31 Dec 2024 |
Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q1 2025
As of 31 Mar 2025,
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by
191 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,088,777 shares.
The largest 10 holders included
FMR LLC, Deep Track Capital, LP, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., BAKER BROS. ADVISORS LP, BlackRock, Inc., ARMISTICE CAPITAL, LLC, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, and Alpine Global Management, LLC.
This page lists
192
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
186
Q1 2025 holders
191
Holder diff
5
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.